Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH100 in T2DM with Recent Cardiovascular Complications
NCT04141241Phase 2Completed
- Sponsor
- Bota Bio
- Start
- Mar 2016
- Primary completion
- May 2018
- Modality
- Botanical Extract
01
Overview
Phase 2, randomised, double-blind trial of ecklonia cava extract in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Bota Bio. Primary endpoint: high-sensitivity C-reactive protein at 12 weeks. Started Mar 2016; status: completed.
02
Drugs
ecklonia cava extract
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04141241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04141241.